top of page

Welcome to
Alera Bio

Biology drives us. 

Patients define us.

Revolutionizing Life-Changing
Therapies for Neurological Conditions 

Blue Background.jpeg

Our Clear Mission

Advancing Science and Empowering Hope.

At Alera Bio, our mission is to push the boundaries of biotech innovation for patients who have neurological deficits. With a focus on MCT-8 deficiency, we are dedicated to developing therapies that address critical unmet needs and improve patient outcomes.

Our Lead Compound

Our lead asset - AB-101 is a proprietary formulation designed to address both the endocrinological AND the neurological symptoms of MCT-8 Deficiency. 

Neuron.jpeg

The Science Driving Us

Science-Driven Innovation 

Our cutting-edge approach leverages a proprietary formulation that targets MCT-8 deficiency. This therapeutic approach is designed to restore normal thyroid levels throughout the body AND improve neurological symptoms to enhance quality of life for those with this rare disorder

Improves Cognitive Function

Addresses brain-specific deficiencies to unlock neurodevelopmental potential.

Normalizes Thyroid Transport â€‹

Restores thyroid hormone levels in target tissues.

Provides Systemic Benefits

Mitigates peripheral complications of hormone imbalances.

Patient-First Principles

Developing compound by addressing the needs of children and their caregivers

Efficacy & Safety Focused 

Balanced approach to allow patients to safely use and treat this condition

Family.jpeg

Patient & Family Support

Compassionate Support Every Step of the Way

We are more than a biotech company – we are partners in your journey. Our team is dedicated to providing education, resources, and compassionate care for patients and families navigating MCT-8 deficiency and other rare conditions.

bottom of page